DrugPatentWatch Database Preview
AXID AR Drug Profile
or, see our see our flat-rate plans
Which patents cover Axid Ar, and when can generic versions of Axid Ar launch?
The generic ingredient in AXID AR is nizatidine. There are seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the nizatidine profile page.
Summary for AXID AR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 45 |
| Patent Applications: | 2,959 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for AXID AR |
| DailyMed Link: | AXID AR at DailyMed |
Medical Subject Heading (MeSH) Categories for AXID AR
Synonyms for AXID AR
| (E)-1-N'-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine |
| (E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N'-methyl-2-nitroethene-1,1-diamine |
| (E)-N-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine |
| (E)-N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)thio]ethyl}-N'-methyl-2-nitroethene-1,1-diamine |
| (E)-N1'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine |
| (E)-N1'-[2-[[2-[(dimethylamino)methyl]-4-thiazolyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine |
| [(E)-1-({2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl}amino)-2-nitroethenyl](methyl)amine |
| 1,1-Ethenediamine, N-(2-(((2-((dimethylamino)methyl)-4-thiazoly)methyl)thio)ethyl)-N'-methyl-2-nitro- |
| 1,1-Ethenediamine, N-(2-(((2-((dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro- |
| 1,1-ethenediamine, n-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-n'-methyl-2-nitro- |
| 1,1-Ethenediamine, N'-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-N-methyl-2-nitro- |
| 76963-41-2 |
| 963N412 |
| A838919 |
| AB00698253_09 |
| AB00698253-07 |
| AB0106214 |
| AB2000352 |
| AC-5272 |
| AC1MHW19 |
| AC1Q1WQW |
| AC1Q40UA |
| Acinon |
| Acinon (TN) |
| AKOS015900643 |
| Ambap76963-41-2 |
| Antizid |
| Axid |
| Axid (TN) |
| BIDD:GT0761 |
| BRD-K92193792-001-01-7 |
| BRN 4846056 |
| C07270 |
| C12H21N5O2S2 |
| Calmaxid |
| CAS-76963-41-2 |
| CCG-100836 |
| CHEBI:7601 |
| CHEMBL653 |
| CPD000466384 |
| Cronizat |
| CS-2350 |
| D00440 |
| D0Q9DK |
| DB00585 |
| dimethyl[(4-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}-1,3-thiazol-2-yl)methyl]amine |
| dimethyl[(4-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}-1,3-thiazol-2-yl)methyl]amine |
| Distaxid |
| EBD34008 |
| Galitidin |
| Gastrax |
| GTPL7248 |
| HE004790 |
| HE337554 |
| HE387409 |
| HMS2051K04 |
| HMS2094A15 |
| HMS2235N05 |
| HS-0083 |
| HSDB 3574 |
| HY-B0310 |
| I14-0503 |
| L000761 |
| LS-67650 |
| LY 139037 |
| LY-139037 |
| LY-139037, Nizatidine |
| MLS000759518 |
| MLS001076680 |
| MLS001424001 |
| MolPort-003-849-605 |
| MolPort-027-655-252 |
| N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine |
| N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamin |
| N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamine |
| N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine |
| Naxidine |
| NC00086 |
| NCGC00016934-01 |
| NCGC00016934-02 |
| NE47126 |
| Niatidine |
| Niaztidine |
| Nizatidina |
| Nizatidina [Spanish] |
| nizatidine |
| Nizatidine (JAN/USP/INN) |
| Nizatidine (JP17/USP/INN) |
| Nizatidine [USAN:BAN:INN:JAN] |
| Nizatidine-d3 |
| Nizatidine, analytical standard |
| Nizatidinum |
| Nizatidinum [Latin] |
| Nizax |
| Nizaxid |
| NSC-759289 |
| NSC759289 |
| Panaxid |
| Pharmakon1600-01505985 |
| Prestwick2_000921 |
| SAM001246752 |
| SBI-0206937.P001 |
| SC-15260 |
| SCHEMBL769 |
| SCHEMBL770 |
| SGXXNSQHWDMGGP-IZZDOVSWSA-N |
| SMR000466384 |
| Splendil ER |
| Tazac |
| Tazac (TN) |
| Tazac;Axid;Axid AR |
| Ulcosol |
| Ulxid |
| Zanizal |
| ZE-101 |
| ZINC1530736 |
| Zinga |
| ZL-101 |
US Patents and Regulatory Information for AXID AR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | AXID AR | nizatidine | TABLET;ORAL | 020555-001 | May 9, 1996 | OTC | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
Expired US Patents for AXID AR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | AXID AR | nizatidine | TABLET;ORAL | 020555-001 | May 9, 1996 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
or, see our see our flat-rate plans
